Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 4 47-4, 2003, Pages

  Gustavson, Stephanie M ^a,b   Chu, Chang An ^a   Nishizawa, Makoto ^a   Farmer, Ben ^a   Neal, Doss ^a   Yang, Ying ^a   Donahue, E Patrick ^a   Flakoll, Paul ^a   Cherrington, Alan D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Canine; Counterregulatory hormones; Gluconeogenesis; Glycogenolysis

Indexed keywords

ADRENALIN; GLUCAGON; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE INFUSION; GLYCOGENOLYSIS; HORMONAL REGULATION; HORMONE ACTION; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; LIVER FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0037376921     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00308.2002     Document Type: Article

References (75)

1. Ahlborg G, Hagenfeldt L, and Wahren J. Influence of lactate infusion on glucose and FFA metabolism in man. Scand J Clin Lab Invest 36: 193-201, 1976.
2. Bertin E, Arner P, Bolinder J, and Hagstrom-Toft E. Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo. J Clin Endocrinol Metab 86: 1229-1234, 2001.
3. Bjorntorp P. The effect of lactic acid on adipose tissue metabolism in vitro. Acta Med Scand 178: 253-255, 1965.
4. Burcelin R, Katz EB, and Charron MJ. Molecular and cellular aspects of the glucagon receptor: role in diabetes and metabolism. Diabetes Metab 22: 373-396, 1996.
5. Chen X, Iqbal N, and Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103: 365-372, 1999.
6. Cherrington AD, Fuchs H, Stevenson RW, Williams PE, Alberti KG, and Steiner KE. Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs. Am J Physiol Endocrinol Metab 247: E137-E144, 1984.
7. Cherrington AD, Williams PE, Shulman GI, and Lacy WW. Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog. Diabetes 30: 180-187, 1981.
8. Chhibber VL, Soriano C, and Tayek JA. Effects of low-dose and high-dose glucagon on glucose production and gluconeogenesis in humans. Metabolism 49: 39-46, 2000.
9. Chu CA, Sherck SM, Igawa K, Sindelar DK, Neal DW, Emshwiller M, and Cherrington AD. Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs. Am J Physiol Endocrinol Metab 282: E402-E411, 2002.
10. Chu CA, Sindelar DK, Neal DW, Allen EJ, Donahue EP, and Cherrington AD. Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. J Clin Invest 99: 1044-1056, 1997.
11. Chu CA, Sindelar DK, Neal DW, and Cherrington AD. Direct effects of catecholamines on hepatic glucose production in conscious dog are due to glycogenolysis. Am J Physiol Endocrinol Metab 271: E127-E137, 1996.
12. Chu CA, Sindelar DK, Neal DW, and Cherrington AD. Portal adrenergic blockade does not inhibit the gluconeogenic effects of circulating catecholamines on the liver. Metabolism 46: 458-465, 1997.
13. Clore JN, Glickman PS, Nestler JE, and Blackard WG. In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans. Am J Physiol Endocrinol Metab 261: E425-E429, 1991.
14. Clutter WE, Bier DM, Shah SD, and Cryer PE. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest 66: 94-101, 1980.
15. Connolly CC, Stevenson RW, Neal DW, Wasserman DH, and Cherrington AD. The effects of lactate loading on alanine and glucose metabolism in the conscious dog. Metabolism 42: 154-161, 1993.
16. Coppack SW, Jensen MD, and Miles JM. In vivo regulation of lipolysis in humans. J Lipid Res 35: 177-193, 1994.
17. DeBodo RC, Steele F, Altszuler N, Dunn A, and Bishop JS. On the hormonal regulation of carbohydrate metabolism: studies with 14 C glucose. Recent Prog Horm Res 19: 445-488, 1963.
18. Diamond MP, Rollings RC, Steiner KE, Williams PE, Lacy WW, and Cherrington AD. Effect of alanine concentration independent of changes in insulin and glucagon on alanine and glucose homeostasis in the conscious dog. Metabolism 37: 28-33, 1988.
19. Dobbins RL, Davis SN, Neal D, Caumo A, Cobelli C, and Cherrington AD. Rates of glucagon activation and deactivation of hepatic glucose production in conscious dogs. Metabolism 47: 135-142, 1998.
20. Dobbins RL, Davis SN, Neal DW, Cobelli C, and Cherrington AD. Pulsatility does not alter the response to a physiological increment in glucagon in the conscious dog. Am J Physiol Endocrinol Metab 266: E467-E478, 1994.
21. Eigler N, Sacca L, and Sherwin RS. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia. J Clin Invest 63: 114-123, 1979.
22. Exton JH. Mechanisms of hormonal regulation of hepatic glucose metabolism. Diabetes Metab Rev 3: 163-183, 1987.
23. Fosgerau K, Mittelman SD, Sunehag A, Dea MK, Lundgren K, and Bergman RN. Lack of hepatic "interregulation" during inhibition of glycogenolysis in a canine model. Am J Physiol Endocrinol Metab 281: E375-E383, 2001.
24. Gerich JE. Control of glycaemia. Baillieres Clin Endocrinol Metab 7: 551-586, 1993.
25. Gerich JE, Meyer C, and Stumvoll MW. Hormonal control of renal and systemic glutamine metabolism. J Nutr 130: 995S-1001S, 2000.
26. Goldstein RE, Rossetti L, Palmer BA, Liu R, Massillon D, Scott M, Neal D, Williams P, Peeler B, and Cherrington AD. Effects of fasting and glucocorticoids on hepatic gluconeogenesis assessed using two independent methods in vivo. Am J Physiol Endocrinol Metab 283: E946-E957, 2002.
27. Gravholt CH, Moller N, Jensen MD, Christiansen JS, and Schmitz O. Physiological levels of glucagon do not influence lipolysis in abdominal adipose tissue as assessed by microdialysis. J Clin Endocrinol Metab 86: 2085-2089, 2001.
28. Hamilton KS, Gibbons FK, Bracy DP, Lacy DB, Cherrington AD, and Wasserman DH. Effect of prior exercise on the partitioning of an intestinal glucose load between splanchnic bed and skeletal muscle. J Clin Invest 98: 125-135, 1996.
29. Hendrick GK, Frizzell RT, and Cherrington AD. Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting. Am J Physiol Endocrinol Metab 253: E443-E452, 1987.
30. Hopgood MF, Clark MG, and Ballard FJ. Protein degradation in hepatocyte monolayers. Effects of glucagon, adenosine 3′:5′-cyclic monophosphate and insulin. Biochem J 186: 71-79, 1980.
31. Hue L. Regulation of gluconeogenesis in the liver. In: Handbook of Physiology: The Endocrine Pancreas and Regulation of Metabolism. Bethesda, MD: Am. Physiol. Soc., 2001, vol. II, sect. 7, chapt. 20, p. 649-657.
32. Issekutz B and Miller H. Plasma free fatty acids during exercise and the effect of lactic acid. Proc Soc Exp Biol Med 110: 237-239, 1962.
33. Jahoor F, Peters EJ, and Wolfe RR. The relationship between gluconeogenic substrate supply and glucose production in humans. Am J Physiol Endocrinol Metab 258: E288-E296, 1990.
34. Jenssen T, Nurjhan N, Consoli A, and Gerich JE. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. J Clin Invest 86: 489-497, 1990.
35. Jungermann K and Katz N. Functional specialization of different hepatocyte populations. Physiol Rev 69: 708-764, 1989.
36. Kilberg MS. Amino acid transport in isolated rat hepatocytes. J Membr Biol 69: 1-12, 1982.
37. Kilberg MS, Barber EF, and Handlogten ME. Characteristics and hormonal regulation of amino acid transport system A in isolated rat hepatocytes. Curr Top Cell Regul 25: 133-163, 1985.
38. Kilberg MS, Stevens BR, and Novak DA. Recent advances in mammalian amino acid transport. Annu Rev Nutr 13: 137-165, 1993.
39. Kraus-Friedmann N and Feng L. The role of intracellular Ca2+ in the regulation of gluconeogenesis. Metabolism 45: 389-403, 1996.
40. Liljenquist JE, Bomboy JD, Lewis SB, Sinclair-Smith BC, Felts PW, Lacy WW, Crofford OB, and Liddle GW. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men. J Clin Invest 53: 198-204, 1974.
41. Magnusson I, Rothman DL, Gerard DP, Katz LD, and Shulman GI. Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes 44: 185-189, 1995.
42. Mari A. Estimation of the rate of appearance in the nonsteady state with a two-compartment model. Am J Physiol Endocrinol Metab 263: E400-E415, 1992.
43. McGuinness OP, Burgin K, Moran C, Bracy D, and Cherrington AD. Role of glucagon in the metabolic response to stress hormone infusion in the conscious dog. Am J Physiol Endocrinol Metab 266: E438-E447, 1994.
44. Miller H, Issekutz B, and Rodahl K. Effect of exercise on the metabolism of fatty acids in the dog. Am J Physiol 205: 167-172, 1963.
45. Mortimore GE, Poso AR, Kadowaki M, and Wert JJ Jr. Multiphasic control of hepatic protein degradation by regulatory amino acids. General features and hormonal modulation. J Biol Chem 262: 16322-16327, 1987.
46. Mortimore GE, Poso AR, and Lardeux BR. Mechanism and regulation of protein degradation in liver. Diabetes Metab Rev 5: 49-70, 1989.
47. Myers SR, Biggers DW, Neal DW, and Cherrington AD. Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. J Clin Invest 88: 158-167, 1991.
48. Parrilla R, Goodman MN, and Toews CJ. Effect of glucagon: insulin ratios on hepatic metabolism. Diabetes 23: 725-731, 1974.
49. Pilkis SJ, Claus TH, and el-Maghrabi MR. The role of cyclic AMP in rapid and long-term regulation of gluconeogenesis and glycolysis. Adv Second Messenger Phosphoprotein Res 22: 175-191, 1988.
50. Pilkis SJ and Granner DK. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 54: 885-909, 1992.
51. Pozefsky T, Tancredi RG, Moxley RT, Dupre J, and Tobin JD. Metabolism of forearm tissues in man. Studies with glucagon. Diabetes 25: 128-135, 1976.
52. Puhakainen I and Yki-Jarvinen H. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes 42: 1694-1699, 1993.
53. Radziuk J and Pye S. Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes Metab Res Rev 17: 250-272, 2001.
54. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14: 263-283, 1998.
55. Randle PJ, Kerbey AL, and Espinal J. Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. Diabetes Metab Rev 4: 623-638, 1988.
56. Rizza R, Haymond M, Cryer P, and Gerich J. Differential effects of epinephrine on glucose production and disposal in man. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E356-E362, 1979.
57. Rosa F. Ultrastructural changes produced by glucagon, cyclic 3′5′-AMP and epinephrine on perfused rat livers. J Ultrastruct Res 34: 205-213, 1971.
58. Ruderman NB and Berger M. The formation of glutamine and alanine in skeletal muscle. J Biol Chem 249: 5500-5506, 1974.
59. Sacca L, Vigorito C, Cicala M, Corso G, and Sherwin RS. Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans. Am J Physiol Endocrinol Metab 245: E294-E302, 1983.
60. Satake S, Moore MC, Igawa K, Converse M, Farmer B, Neal DW, and Cherrington AD. Direct and indirect effects of insulin on glucose uptake and storage by the liver. Diabetes 51: 1663-1671, 2002.
61. Schworer CM and Mortimore GE. Glucagon-induced autophagy and proteolysis in rat liver: mediation by selective deprivation of intracellular amino acids. Proc Natl Acad Sci USA 76: 3169-3173, 1979.
62. Shamoon H, Hendler R, and Sherwin RS. Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. J Clin Endocrinol Metab 52: 1235-1241, 1981.
63. Sherck SM, Shiota M, Saccomando J, Cardin S, Allen EJ, Hastings JR, Neal DW, Williams PE, and Cherrington AD. Pancreatic response to mild non-insulin-induced hypoglycemia does not involve extrinsic neural input. Diabetes 50: 2487-2496, 2001.
64. Shiota M, Jackson PA, Bischoff H, McCaleb M, Scott M, Monohan M, Neal DW, and Cherrington AD. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs. Am J Physiol Endocrinol Metab 273: E868-E879, 1997.
65. Shulman GI, Lacy WW, Liljenquist JE, Keller U, Williams PE, and Cherrington AD. Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog. J Clin Invest 65: 496-505, 1980.
66. Stevenson RW, Steiner KE, Connolly CC, Fuchs H, Alberti KG, Williams PE, and Cherrington AD. Dose-related effects of epinephrine on glucose production in conscious dogs. Am J Physiol Endocrinol Metab 260: E363-E370, 1991.
67. Stevenson RW, Steiner KE, Davis MA, Hendrick GK, Williams PE, Lacy WW, Brown L, Donahue P, Lacy DB, and Cherrington AD. Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivo. Diabetes 36: 382-389, 1987.
68. Stingl H, Krssak M, Krebs M, Bischof MG, Nowotny P, Furnsinn C, Shulman GI, Waldhausl W, and Roden M. Lipid-dependent control of hepatic glycogen stores in healthy humans. Diabetologia 44: 48-54, 2001.
69. Stumvoll M, Meyer C, Kreider M, Perriello G, and Gerich J. Effects of glucagon on renal and hepatic glutamine gluconeogenesis in normal postabsorptive humans. Metabolism 47: 1227-1232, 1998.
70. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, and Stein DT. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol Endocrinol Metab 276: E977-E989, 1999.
71. Wahren J, Felig P, Ahlborg G, and Jorfeldt L. Glucose metabolism during leg exercise in man. J Clin Invest 50: 2715-2725, 1971.
72. Wall JS, Steele R, DeBodo RC, and Altszuler N. Effect of insulin in utilization and production of circulating glucose. Am J Physiol 189: 43-50, 1957.
73. Williamson JR, Kreisberg RA, and Felts PW. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci USA 56: 247-254, 1966.
74. Wolfe RR, Jahoor F, and Shaw JH. Effect of alanine infusion on glucose and urea production in man. J Parenter Enteral Nutr 11: 109-111, 1987.
75. Woodside KH, Ward WF, and Mortimore GE. Effects of glucagon on general protein degradation and synthesis in perfused rat liver. J Biol Chem 249: 5458-5463, 1974.